Related Experiment Video
Updated: Jun 18, 2026

Chromosome Preparation From Cultured Cells
Published on: January 28, 2014
A Case of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia in a 26-Year-Old Pregnant Woman
Natalie Shaykh1, Falguni Patel1, Luke Stachler1
1Internal Medicine, University of Florida College of Medicine - Jacksonville, Jacksonville, USA.
Insights
Acute lymphoblastic leukemia (ALL) is a rare blood cancer. This case highlights a multidisciplinary treatment approach for Philadelphia chromosome-positive ALL (Ph+ ALL) in an adult patient from a unique demographic.
Area of Science:
- Hematology
- Oncology
Background:
- Acute lymphoblastic leukemia (ALL) is a rare, aggressive blood cancer originating in bone marrow, marked by immature lymphocyte overgrowth.
- While common in children, ALL presents bimodal peaks, affecting early childhood and individuals around age 50.
- Cytogenetic abnormalities, notably the Philadelphia chromosome (Ph), are present in 20-33% of adult ALL cases.
Observation:
- This case report focuses on a patient diagnosed with Philadelphia chromosome-positive ALL (Ph+ ALL).
- The patient's demographic profile is unique, presenting atypical characteristics for this subtype of leukemia.
- The study emphasizes the critical role of a multidisciplinary approach in managing this complex condition.
Findings:
- The case underscores the effectiveness of a comprehensive, team-based strategy in treating Ph+ ALL.
- Treatment tailored to the patient's unique characteristics and disease profile yielded positive outcomes.
- Integration of various medical specialties was crucial for optimal patient management.
Implications:
- This case provides valuable insights into managing Ph+ ALL in specific patient populations.
- It highlights the importance of personalized medicine and multidisciplinary collaboration in hematologic oncology.
- The findings may inform future treatment protocols for adult Ph+ ALL, particularly in unique demographic groups.
Abstract:
Acute lymphoblastic leukemia (ALL) is an uncommon and rapidly progressing blood cancer originating in the bone marrow, characterized by the abnormal proliferation of immature lymphocytes. Although most cases of ALL are observed in children, the disease pattern shows two peaks: one in early childhood and another around the age of 50. Approximately a fifth to a third of adults diagnosed with ALL exhibit cytogenetic abnormalities involving the Philadelphia chromosome. Despite the existence of several studies on Philadelphia chromosome-positive ALL (Ph+ ALL), our case accentuates the use of a multi-disciplinary approach to treatment and involves a patient from a unique demographic.
More Related Videos
06:08Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model
Published on: February 10, 2023
07:39Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025